share_log

Cyclacel Pharmaceuticals Inc | SC 13G: Statement of acquisition of beneficial ownership by individuals-Schonfeld Strategic Advisors LLC(6.14%)

Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | SC 13G:超過5%持股股東披露文件-Schonfeld Strategic Advisors LLC(6.14%)

美股SEC公告 ·  2023/02/14 16:31
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息